Your browser doesn't support javascript.
Healthcare disparities in telemedicine for rheumatology care.
Jackson, Lesley E; Danila, Maria I.
  • Jackson LE; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Curr Opin Rheumatol ; 34(3): 171-178, 2022 05 01.
Article in English | MEDLINE | ID: covidwho-1705440
ABSTRACT
PURPOSE OF REVIEW We summarize the recent literature published in the last 2 years on healthcare disparities observed in the delivery of rheumatology care by telemedicine. We highlight recent research dissecting the underpinnings of healthcare disparities and identify potentially modifiable contributing factors. RECENT

FINDINGS:

The COVID-19 pandemic has had major impacts on care delivery and has led to a pronounced increase in telemedicine use in rheumatology practice. Telemedicine services are disproportionately underutilized by racial/ethnic minority groups and among patients with lower socioeconomic status. Disparities in telemedicine access and use among vulnerable populations threatens to exacerbate existing outcome inequalities affecting people with rheumatic disease.

SUMMARY:

Telemedicine has the potential to expand rheumatology services by reaching traditionally underserved communities. However, some areas lack the infrastructure and technology to engage in telemedicine. Addressing health equity and the digital divide may help foster more inclusive telemedicine care.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Rheumatology / Telemedicine / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Curr Opin Rheumatol Journal subject: Rheumatology Year: 2022 Document Type: Article Affiliation country: Bor.0000000000000869

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Rheumatology / Telemedicine / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Curr Opin Rheumatol Journal subject: Rheumatology Year: 2022 Document Type: Article Affiliation country: Bor.0000000000000869